Cell-Free Human Papillomavirus DNA Is a Sensitive Biomarker for Prognosis and for Early Detection of Relapse in Locally Advanced Cervical Cancer.

Lars Sivars Cecilia Jylhä Ylva Crona Guterstam Mark Zupancic Britta Lindqvist Magnus Nordenskjöld Emma Tham Kristina Hellman

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2024)

ctHPV DNA in follow-up plasma is a promising prognostic biomarker in patients with LACC, useful for analysis of response to therapy and for early detection of relapse.

Keyphrases

cell free
circulating tumor
locally advanced
free survival
squamous cell carcinoma
rectal cancer
neoadjuvant chemotherapy
radiation therapy
stem cells
clinical trial
phase ii study
single molecule
circulating tumor cells
bone marrow
study protocol
replacement therapy